Predictors of Medication-Related Problems among Medicaid Patients Participating in a Pharmacist-Provided Telephonic Medication Therapy Management Program
Identifieur interne :
004396 ( PascalFrancis/Curation );
précédent :
004395;
suivant :
004397
Predictors of Medication-Related Problems among Medicaid Patients Participating in a Pharmacist-Provided Telephonic Medication Therapy Management Program
Auteurs : Margie E. Snyder [
États-Unis] ;
Caitlin K. Frail [
États-Unis] ;
Heather Jaynes [
États-Unis] ;
Karen S. Pater [
États-Unis] ;
Alan J. Zillich [
États-Unis]
Source :
-
Pharmacotherapy [ 0277-0008 ] ; 2014.
RBID : Pascal:15-0018769
Descripteurs français
- Pascal (Inist)
- Facteur prédictif,
Médicament,
Traitement,
Assurance maladie,
Homme,
Personnel sanitaire,
Pharmacien,
Conduite à tenir,
Programme,
Pronostic,
Medicaid.
- Wicri :
English descriptors
Abstract
STUDY OBJECTIVE To identify predictors of medication-related problems (MRPs) among Medicaid patients participating in a telephonic medication therapy management (MTM) program. DESIGN Retrospective analysis of data from patients enrolled in a previously published study. DATA SOURCES Two Medicaid administrative claims file databases (for health care utilization and prescription dispensing information) and one pharmacy organization file for MTM program information. PATIENTS Seven hundred twelve adult Medicaid patients who participated in a statewide pharmacist-provided telephone-based MTM program and who received an initial medication therapy review. MEASUREMENTS AND MAIN RESULTS The primary dependent variable was the number of MRPs detected during the initial medication therapy review. Secondary dependent variables were the detection of one or more MRPs related to indication, effectiveness, safety, and adherence. Predictor variables were selected a priori that, from the literature and our own practice experiences, were hypothesized as being potentially associated with MRPs: demographics, comorbidities, medication use, and health care utilization. Bivariate analyses were performed, and multivariable models were constructed. All predictor variables with significant associations (defined a priori as p<0.1) with the median number of MRPs detected were then entered into a three-block multiple linear regression model. The overall model was significant (p<0.001, R2 = 0.064). Significant predictors of any MRPs (p<0.05) were total number of medications, obesity, dyslipidemia, and one or more emergency department visits in the past 3 months. For indication-related MRPs, the model was significant (p<0.001, R2 = 0.049), and predictors included female sex, obesity, dyslipidemia, and total number of medications (p<0.05). For effectiveness-related MRPs, the model was significant (p<0.001, R2 = 0.054), and predictors included bone disease and dyslipidemia (p<0.05). For safety-related MRPs, the model was significant (p<0.001, R2 = 0.046), and dyslipidemia was a predictor (p<0.05). No significant predictors of adherence-related MRPs were identified. CONCLUSION This analysis supports the relative importance of number of medications as a predictor of MRPs in the Medicaid population and identifies other predictors. However, given the models' low R2 values, these findings indicate that other unknown factors are clearly important and that criteria commonly used for determining MTM eligibility may be inadequate in identifying appropriate patients for MTM in a Medicaid population.
pA |
A01 | 01 | 1 | | @0 0277-0008 |
---|
A02 | 01 | | | @0 PHPYDQ |
---|
A03 | | 1 | | @0 Pharmacotherapy |
---|
A05 | | | | @2 34 |
---|
A06 | | | | @2 10 |
---|
A08 | 01 | 1 | ENG | @1 Predictors of Medication-Related Problems among Medicaid Patients Participating in a Pharmacist-Provided Telephonic Medication Therapy Management Program |
---|
A11 | 01 | 1 | | @1 SNYDER (Margie E.) |
---|
A11 | 02 | 1 | | @1 FRAIL (Caitlin K.) |
---|
A11 | 03 | 1 | | @1 JAYNES (Heather) |
---|
A11 | 04 | 1 | | @1 PATER (Karen S.) |
---|
A11 | 05 | 1 | | @1 ZILLICH (Alan J.) |
---|
A14 | 01 | | | @1 Department of Pharmacy Practice, Purdue University College of Pharmacy @2 Indianapolis, Indiana @3 USA @Z 1 aut. @Z 3 aut. @Z 5 aut. |
---|
A14 | 02 | | | @1 Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy @2 Minneapolis, Minnesota @3 USA @Z 2 aut. |
---|
A14 | 03 | | | @1 Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy @2 Pittsburgh, Pennsylvania @3 USA @Z 4 aut. |
---|
A14 | 04 | | | @1 Center for Implementing Evidence-Based Practices, Roudebush VA Medical Center @2 Indianapolis, Indiana @3 USA @Z 5 aut. |
---|
A20 | | | | @1 1022-1032 |
---|
A21 | | | | @1 2014 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 19165 @5 354000504591800030 |
---|
A44 | | | | @0 0000 @1 © 2015 INIST-CNRS. All rights reserved. |
---|
A45 | | | | @0 50 ref. |
---|
A47 | 01 | 1 | | @0 15-0018769 |
---|
A60 | | | | @1 P @2 C |
---|
A61 | | | | @0 A |
---|
A64 | 01 | 1 | | @0 Pharmacotherapy |
---|
A66 | 01 | | | @0 USA |
---|
C01 | 01 | | ENG | @0 STUDY OBJECTIVE To identify predictors of medication-related problems (MRPs) among Medicaid patients participating in a telephonic medication therapy management (MTM) program. DESIGN Retrospective analysis of data from patients enrolled in a previously published study. DATA SOURCES Two Medicaid administrative claims file databases (for health care utilization and prescription dispensing information) and one pharmacy organization file for MTM program information. PATIENTS Seven hundred twelve adult Medicaid patients who participated in a statewide pharmacist-provided telephone-based MTM program and who received an initial medication therapy review. MEASUREMENTS AND MAIN RESULTS The primary dependent variable was the number of MRPs detected during the initial medication therapy review. Secondary dependent variables were the detection of one or more MRPs related to indication, effectiveness, safety, and adherence. Predictor variables were selected a priori that, from the literature and our own practice experiences, were hypothesized as being potentially associated with MRPs: demographics, comorbidities, medication use, and health care utilization. Bivariate analyses were performed, and multivariable models were constructed. All predictor variables with significant associations (defined a priori as p<0.1) with the median number of MRPs detected were then entered into a three-block multiple linear regression model. The overall model was significant (p<0.001, R2 = 0.064). Significant predictors of any MRPs (p<0.05) were total number of medications, obesity, dyslipidemia, and one or more emergency department visits in the past 3 months. For indication-related MRPs, the model was significant (p<0.001, R2 = 0.049), and predictors included female sex, obesity, dyslipidemia, and total number of medications (p<0.05). For effectiveness-related MRPs, the model was significant (p<0.001, R2 = 0.054), and predictors included bone disease and dyslipidemia (p<0.05). For safety-related MRPs, the model was significant (p<0.001, R2 = 0.046), and dyslipidemia was a predictor (p<0.05). No significant predictors of adherence-related MRPs were identified. CONCLUSION This analysis supports the relative importance of number of medications as a predictor of MRPs in the Medicaid population and identifies other predictors. However, given the models' low R2 values, these findings indicate that other unknown factors are clearly important and that criteria commonly used for determining MTM eligibility may be inadequate in identifying appropriate patients for MTM in a Medicaid population. |
---|
C02 | 01 | X | | @0 002B02 |
---|
C03 | 01 | X | FRE | @0 Facteur prédictif @5 01 |
---|
C03 | 01 | X | ENG | @0 Predictive factor @5 01 |
---|
C03 | 01 | X | SPA | @0 Factor predictivo @5 01 |
---|
C03 | 02 | X | FRE | @0 Médicament @5 02 |
---|
C03 | 02 | X | ENG | @0 Drug @5 02 |
---|
C03 | 02 | X | SPA | @0 Medicamento @5 02 |
---|
C03 | 03 | X | FRE | @0 Traitement @5 03 |
---|
C03 | 03 | X | ENG | @0 Treatment @5 03 |
---|
C03 | 03 | X | SPA | @0 Tratamiento @5 03 |
---|
C03 | 04 | X | FRE | @0 Assurance maladie @5 04 |
---|
C03 | 04 | X | ENG | @0 Health insurance @5 04 |
---|
C03 | 04 | X | SPA | @0 Seguro enfermedad @5 04 |
---|
C03 | 05 | X | FRE | @0 Homme @5 05 |
---|
C03 | 05 | X | ENG | @0 Human @5 05 |
---|
C03 | 05 | X | SPA | @0 Hombre @5 05 |
---|
C03 | 06 | X | FRE | @0 Personnel sanitaire @5 06 |
---|
C03 | 06 | X | ENG | @0 Health staff @5 06 |
---|
C03 | 06 | X | SPA | @0 Personal sanitario @5 06 |
---|
C03 | 07 | X | FRE | @0 Pharmacien @5 07 |
---|
C03 | 07 | X | ENG | @0 Chemist @5 07 |
---|
C03 | 07 | X | SPA | @0 Farmacéutico @5 07 |
---|
C03 | 08 | X | FRE | @0 Conduite à tenir @5 08 |
---|
C03 | 08 | X | ENG | @0 Clinical management @5 08 |
---|
C03 | 08 | X | SPA | @0 Actitud médica @5 08 |
---|
C03 | 09 | X | FRE | @0 Programme @5 09 |
---|
C03 | 09 | X | ENG | @0 Program @5 09 |
---|
C03 | 09 | X | SPA | @0 Programa @5 09 |
---|
C03 | 10 | X | FRE | @0 Pronostic @5 10 |
---|
C03 | 10 | X | ENG | @0 Prognosis @5 10 |
---|
C03 | 10 | X | SPA | @0 Pronóstico @5 10 |
---|
C03 | 11 | X | FRE | @0 Medicaid @4 INC @5 86 |
---|
N21 | | | | @1 026 |
---|
N44 | 01 | | | @1 OTO |
---|
N82 | | | | @1 OTO |
---|
|
pR |
A30 | 01 | 1 | ENG | @1 International Society for Pharmacoeconomics and Outcomes Research. Annual European Congress @2 15 @3 Berlin DEU @4 2012-11-03 |
---|
|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000195
Links to Exploration step
Pascal:15-0018769
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Predictors of Medication-Related Problems among Medicaid Patients Participating in a Pharmacist-Provided Telephonic Medication Therapy Management Program</title>
<author><name sortKey="Snyder, Margie E" sort="Snyder, Margie E" uniqKey="Snyder M" first="Margie E." last="Snyder">Margie E. Snyder</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacy Practice, Purdue University College of Pharmacy</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Frail, Caitlin K" sort="Frail, Caitlin K" uniqKey="Frail C" first="Caitlin K." last="Frail">Caitlin K. Frail</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy</s1>
<s2>Minneapolis, Minnesota</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Jaynes, Heather" sort="Jaynes, Heather" uniqKey="Jaynes H" first="Heather" last="Jaynes">Heather Jaynes</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacy Practice, Purdue University College of Pharmacy</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Pater, Karen S" sort="Pater, Karen S" uniqKey="Pater K" first="Karen S." last="Pater">Karen S. Pater</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy</s1>
<s2>Pittsburgh, Pennsylvania</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Zillich, Alan J" sort="Zillich, Alan J" uniqKey="Zillich A" first="Alan J." last="Zillich">Alan J. Zillich</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacy Practice, Purdue University College of Pharmacy</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Center for Implementing Evidence-Based Practices, Roudebush VA Medical Center</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">15-0018769</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 15-0018769 INIST</idno>
<idno type="RBID">Pascal:15-0018769</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000195</idno>
<idno type="wicri:Area/PascalFrancis/Curation">004396</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Predictors of Medication-Related Problems among Medicaid Patients Participating in a Pharmacist-Provided Telephonic Medication Therapy Management Program</title>
<author><name sortKey="Snyder, Margie E" sort="Snyder, Margie E" uniqKey="Snyder M" first="Margie E." last="Snyder">Margie E. Snyder</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacy Practice, Purdue University College of Pharmacy</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Frail, Caitlin K" sort="Frail, Caitlin K" uniqKey="Frail C" first="Caitlin K." last="Frail">Caitlin K. Frail</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy</s1>
<s2>Minneapolis, Minnesota</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Jaynes, Heather" sort="Jaynes, Heather" uniqKey="Jaynes H" first="Heather" last="Jaynes">Heather Jaynes</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacy Practice, Purdue University College of Pharmacy</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Pater, Karen S" sort="Pater, Karen S" uniqKey="Pater K" first="Karen S." last="Pater">Karen S. Pater</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy</s1>
<s2>Pittsburgh, Pennsylvania</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Zillich, Alan J" sort="Zillich, Alan J" uniqKey="Zillich A" first="Alan J." last="Zillich">Alan J. Zillich</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacy Practice, Purdue University College of Pharmacy</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Center for Implementing Evidence-Based Practices, Roudebush VA Medical Center</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Pharmacotherapy</title>
<title level="j" type="abbreviated">Pharmacotherapy</title>
<idno type="ISSN">0277-0008</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Pharmacotherapy</title>
<title level="j" type="abbreviated">Pharmacotherapy</title>
<idno type="ISSN">0277-0008</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chemist</term>
<term>Clinical management</term>
<term>Drug</term>
<term>Health insurance</term>
<term>Health staff</term>
<term>Human</term>
<term>Predictive factor</term>
<term>Prognosis</term>
<term>Program</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Facteur prédictif</term>
<term>Médicament</term>
<term>Traitement</term>
<term>Assurance maladie</term>
<term>Homme</term>
<term>Personnel sanitaire</term>
<term>Pharmacien</term>
<term>Conduite à tenir</term>
<term>Programme</term>
<term>Pronostic</term>
<term>Medicaid</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Médicament</term>
<term>Assurance maladie</term>
<term>Homme</term>
<term>Pharmacien</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">STUDY OBJECTIVE To identify predictors of medication-related problems (MRPs) among Medicaid patients participating in a telephonic medication therapy management (MTM) program. DESIGN Retrospective analysis of data from patients enrolled in a previously published study. DATA SOURCES Two Medicaid administrative claims file databases (for health care utilization and prescription dispensing information) and one pharmacy organization file for MTM program information. PATIENTS Seven hundred twelve adult Medicaid patients who participated in a statewide pharmacist-provided telephone-based MTM program and who received an initial medication therapy review. MEASUREMENTS AND MAIN RESULTS The primary dependent variable was the number of MRPs detected during the initial medication therapy review. Secondary dependent variables were the detection of one or more MRPs related to indication, effectiveness, safety, and adherence. Predictor variables were selected a priori that, from the literature and our own practice experiences, were hypothesized as being potentially associated with MRPs: demographics, comorbidities, medication use, and health care utilization. Bivariate analyses were performed, and multivariable models were constructed. All predictor variables with significant associations (defined a priori as p<0.1) with the median number of MRPs detected were then entered into a three-block multiple linear regression model. The overall model was significant (p<0.001, R<sup>2</sup>
= 0.064). Significant predictors of any MRPs (p<0.05) were total number of medications, obesity, dyslipidemia, and one or more emergency department visits in the past 3 months. For indication-related MRPs, the model was significant (p<0.001, R<sup>2</sup>
= 0.049), and predictors included female sex, obesity, dyslipidemia, and total number of medications (p<0.05). For effectiveness-related MRPs, the model was significant (p<0.001, R<sup>2</sup>
= 0.054), and predictors included bone disease and dyslipidemia (p<0.05). For safety-related MRPs, the model was significant (p<0.001, R<sup>2</sup>
= 0.046), and dyslipidemia was a predictor (p<0.05). No significant predictors of adherence-related MRPs were identified. CONCLUSION This analysis supports the relative importance of number of medications as a predictor of MRPs in the Medicaid population and identifies other predictors. However, given the models' low R<sup>2 </sup>
values, these findings indicate that other unknown factors are clearly important and that criteria commonly used for determining MTM eligibility may be inadequate in identifying appropriate patients for MTM in a Medicaid population.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0277-0008</s0>
</fA01>
<fA02 i1="01"><s0>PHPYDQ</s0>
</fA02>
<fA03 i2="1"><s0>Pharmacotherapy</s0>
</fA03>
<fA08 i1="01" i2="1" l="ENG"><s1>Predictors of Medication-Related Problems among Medicaid Patients Participating in a Pharmacist-Provided Telephonic Medication Therapy Management Program</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SNYDER (Margie E.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>FRAIL (Caitlin K.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>JAYNES (Heather)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>PATER (Karen S.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>ZILLICH (Alan J.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Pharmacy Practice, Purdue University College of Pharmacy</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy</s1>
<s2>Minneapolis, Minnesota</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy</s1>
<s2>Pittsburgh, Pennsylvania</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Center for Implementing Evidence-Based Practices, Roudebush VA Medical Center</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>1022-1032</s1>
</fA20>
<fA21><s1>2014</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>19165</s2>
<s5>354000504591800030</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2015 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>50 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>15-0018769</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA64 i1="01" i2="1"><s0>Pharmacotherapy</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>STUDY OBJECTIVE To identify predictors of medication-related problems (MRPs) among Medicaid patients participating in a telephonic medication therapy management (MTM) program. DESIGN Retrospective analysis of data from patients enrolled in a previously published study. DATA SOURCES Two Medicaid administrative claims file databases (for health care utilization and prescription dispensing information) and one pharmacy organization file for MTM program information. PATIENTS Seven hundred twelve adult Medicaid patients who participated in a statewide pharmacist-provided telephone-based MTM program and who received an initial medication therapy review. MEASUREMENTS AND MAIN RESULTS The primary dependent variable was the number of MRPs detected during the initial medication therapy review. Secondary dependent variables were the detection of one or more MRPs related to indication, effectiveness, safety, and adherence. Predictor variables were selected a priori that, from the literature and our own practice experiences, were hypothesized as being potentially associated with MRPs: demographics, comorbidities, medication use, and health care utilization. Bivariate analyses were performed, and multivariable models were constructed. All predictor variables with significant associations (defined a priori as p<0.1) with the median number of MRPs detected were then entered into a three-block multiple linear regression model. The overall model was significant (p<0.001, R<sup>2</sup>
= 0.064). Significant predictors of any MRPs (p<0.05) were total number of medications, obesity, dyslipidemia, and one or more emergency department visits in the past 3 months. For indication-related MRPs, the model was significant (p<0.001, R<sup>2</sup>
= 0.049), and predictors included female sex, obesity, dyslipidemia, and total number of medications (p<0.05). For effectiveness-related MRPs, the model was significant (p<0.001, R<sup>2</sup>
= 0.054), and predictors included bone disease and dyslipidemia (p<0.05). For safety-related MRPs, the model was significant (p<0.001, R<sup>2</sup>
= 0.046), and dyslipidemia was a predictor (p<0.05). No significant predictors of adherence-related MRPs were identified. CONCLUSION This analysis supports the relative importance of number of medications as a predictor of MRPs in the Medicaid population and identifies other predictors. However, given the models' low R<sup>2 </sup>
values, these findings indicate that other unknown factors are clearly important and that criteria commonly used for determining MTM eligibility may be inadequate in identifying appropriate patients for MTM in a Medicaid population.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Facteur prédictif</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Predictive factor</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Factor predictivo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Médicament</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Drug</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Medicamento</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Traitement</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Treatment</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Assurance maladie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Health insurance</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Seguro enfermedad</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Human</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Personnel sanitaire</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Health staff</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Personal sanitario</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Pharmacien</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Chemist</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Farmacéutico</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Conduite à tenir</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Clinical management</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Actitud médica</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Programme</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Program</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Programa</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Pronostic</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Prognosis</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Pronóstico</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Medicaid</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fN21><s1>026</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>International Society for Pharmacoeconomics and Outcomes Research. Annual European Congress</s1>
<s2>15</s2>
<s3>Berlin DEU</s3>
<s4>2012-11-03</s4>
</fA30>
</pR>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004396 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 004396 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:15-0018769
|texte= Predictors of Medication-Related Problems among Medicaid Patients Participating in a Pharmacist-Provided Telephonic Medication Therapy Management Program
}}
| This area was generated with Dilib version V0.6.38. Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021 | |